124 related articles for article (PubMed ID: 7397623)
1. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
[TBL] [Abstract][Full Text] [Related]
2. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
3. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
[TBL] [Abstract][Full Text] [Related]
6. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
7. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
8. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
[TBL] [Abstract][Full Text] [Related]
9. Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Guérin substrains.
Secanella-Fandos S; Luquin M; Julián E
J Urol; 2013 Feb; 189(2):711-8. PubMed ID: 22982433
[TBL] [Abstract][Full Text] [Related]
10. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental metastatic spread by nonspecific stimulants.
Arnold W; Muresian TM; Kiricuta I; Graffi A
Oncology; 1977; 34(4):156-8. PubMed ID: 917448
[TBL] [Abstract][Full Text] [Related]
13. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
14. Adjuvant preoperative and postoperative immunochemotherapy for mammary adenocarcinoma in rats.
Sparks FC; O'Connell TX; Lee YT
Surg Forum; 1973; 24():118-21. PubMed ID: 4618633
[No Abstract] [Full Text] [Related]
15. BCG therapy given as an adjuvant to surgery: prevention of death from metastases from mammary adenocarcinoma in rats.
Sparks FC; O'Connell TX; Lee YT; Breeding JH
J Natl Cancer Inst; 1974 Dec; 53(6):1825-6. PubMed ID: 4474413
[No Abstract] [Full Text] [Related]
16. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison of BCG strains and preparations in immunotherapy of a rat sarcoma.
Willmott N; Pimm MV; Baldwin RW
J Natl Cancer Inst; 1979 Sep; 63(3):787-95. PubMed ID: 288936
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
[TBL] [Abstract][Full Text] [Related]
19. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
Vaage J
Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma.
Lee YT; Khwaja TA
J Surg Oncol; 1977; 9(5):469-79. PubMed ID: 592846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]